![Russell Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di Russell Smith
Precedenti posizioni note di Russell Smith
Società | Posizione | Inizio | Fine |
---|---|---|---|
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Fondatore | 01/01/1998 | 04/12/2008 |
Corporate Officer/Principal | 01/01/1998 | 04/12/2008 | |
Surface Therapeutics Ltd.
![]() Surface Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Surface Therapeutics Ltd. develops novel drugs & diagnostics for asthma and epithelial diseases. It also develops new pharmaceutical products for the treatment of inflammatory epithelial diseases with a focus on the skin and lungs. The company was founded in 2004 and is headquartered in Abingdon, LO. | Presidente | - | - |
Business Boffins Ltd.
![]() Business Boffins Ltd. Miscellaneous Commercial ServicesCommercial Services Business Boffins Ltd. provided education management services. The company was headquartered in Chinnor, the United Kingdom. | Corporate Officer/Principal | - | - |
Prolysis Ltd.
![]() Prolysis Ltd. Pharmaceuticals: MajorHealth Technology Prolysis Ltd. develops and manufactures pharmaceutical products. It develops antibacterial therapy to treat drug resistant infections. The company was founded in 1998 and is headquartered in Kidlington, UK. | Presidente | - | - |
Glide Pharmaceutical Technologies Ltd.
![]() Glide Pharmaceutical Technologies Ltd. Pharmaceuticals: MajorHealth Technology Glide Pharmaceutical Technologies Ltd. developed and manufactured pharmaceutical products. The firm developed SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. It also engaged in developing a non-invasive diagnostic technology that primarily focuses on prostate cancer, which aims to identify clinically significant disease based on a biochemical marker. The company was founded by Charles David Ogilvy Potter on 6th March, 2001 and was headquartered in Abingdon, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
Regno Unito | 6 |
Posizioni
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
President | 1 |
Settori
Health Technology | 5 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Glide Pharmaceutical Technologies Ltd.
![]() Glide Pharmaceutical Technologies Ltd. Pharmaceuticals: MajorHealth Technology Glide Pharmaceutical Technologies Ltd. developed and manufactured pharmaceutical products. The firm developed SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. It also engaged in developing a non-invasive diagnostic technology that primarily focuses on prostate cancer, which aims to identify clinically significant disease based on a biochemical marker. The company was founded by Charles David Ogilvy Potter on 6th March, 2001 and was headquartered in Abingdon, the United Kingdom. | Health Technology |
Business Boffins Ltd.
![]() Business Boffins Ltd. Miscellaneous Commercial ServicesCommercial Services Business Boffins Ltd. provided education management services. The company was headquartered in Chinnor, the United Kingdom. | Commercial Services |
Prolysis Ltd.
![]() Prolysis Ltd. Pharmaceuticals: MajorHealth Technology Prolysis Ltd. develops and manufactures pharmaceutical products. It develops antibacterial therapy to treat drug resistant infections. The company was founded in 1998 and is headquartered in Kidlington, UK. | Health Technology |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Health Technology |
Surface Therapeutics Ltd.
![]() Surface Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Surface Therapeutics Ltd. develops novel drugs & diagnostics for asthma and epithelial diseases. It also develops new pharmaceutical products for the treatment of inflammatory epithelial diseases with a focus on the skin and lungs. The company was founded in 2004 and is headquartered in Abingdon, LO. | Health Technology |
- Borsa valori
- Insiders
- Russell Smith
- Esperienza